
Panfina D 30mg/40mg Capsule SR
Marketer
Elured Labs Pvt Ltd
Salt Composition
Domperidone (30mg) + Pantoprazole (40mg)
Overview Panfina D 30mg/40mg Capsule SR
Gastro-esophageal reflux disease (GERD), dyspepsia, and gastritis are effectively managed with the prescription medication, Panfina D 30mg/40mg SR Capsules. This medication alleviates symptoms like heartburn, stomach pain, and irritation by decreasing stomach acid production. Panfina D also neutralizes existing stomach acid and facilitates gas expulsion, thereby easing discomfort. Administered as directed by your physician, this medication is taken on an empty stomach. Dosage and treatment duration are tailored to your individual needs and response. Discontinuing treatment prematurely may lead to symptom recurrence and condition exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. Common, typically transient, side effects include diarrhea, vomiting, abdominal pain, flatulence, dry mouth, and headache. Report any concerns regarding side effects immediately to your doctor. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions, and if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Panfina D 30mg/40mg Capsule SR
No text provided to rephrase.
Uses of Panfina D 30mg/40mg Capsule SR
Managing gastroesophageal reflux, indigestion, and gastritis.
Major Benefits of Panfina D 30mg/40mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Panfina D 30mg/40mg SR capsules on an empty stomach.
Common Side effects of Panfina D 30mg/40mg Capsule SR:
- Diarrhea
- Stomach pain
- Flatulence
- Dryness in mouth
- Dizziness
- Headache
How to use Panfina D 30mg/40mg Capsule SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Panfina D 30mg/40mg Capsule SR should be swallowed whole; do not crush, chew, or break it. Administer on an empty stomach.
How Panfina D 30mg/40mg Capsule SR works:
Panfina D 30mg/40mg sustained-release capsules contain Domperidone and Pantoprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating efficient food passage. Pantoprazole, a proton pump inhibitor (PPI), lowers stomach acid production, providing relief from acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Panfina D 30mg/40mg SR capsules with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The extended-release Panfina D 30mg/40mg capsule may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Prolonged-release Panfina D 30mg/40mg capsules require careful consideration when breastfeeding. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Driving may be unsafe while taking Panfina D 30mg/40mg SR Capsules, as drowsiness, blurred vision, and dizziness are potential side effects. Refrain from operating a vehicle if you experience these symptoms.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Panfina D 30mg/40mg sustained-release capsules. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Panfina D 30mg/40mg sustained-release capsules in patients with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Panfina D 30mg/40mg Capsule SR :
Should you forget a Panfina D 30mg/40mg Capsule SR dose, administer it promptly. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Panfina D 30mg/40mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
